Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114794) titled 'A Multimodal Deep Learning Framework for Predicting Platinum response and Recurrence Risk from Ovarian Cancer Histopathology' on Dec. 17, 2025.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital

Condition: Ovarian cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-04-30

Target Sample Size: Observation group:400;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=289128

Published by HT Digital Content Services with ...